Essentials of Aprezo 30 mg Glenmark Pharmaceuticals Ltd.: what you need to know
Aprezo 30 mg, produced by Glenmark Pharmaceuticals Ltd., is a medication primarily aimed at managing inflammation. The active ingredient is Apremilast, which works by inhibiting an enzyme known as phosphodiesterase 4 (PDE4). This action helps reduce inflammation in the body. Aprezo is not typically used in sports for performance enhancement but may benefit athletes in terms of recovery if they experience inflammation-related issues. It’s essential to understand that while Aprezo can help manage inflammation, it does not directly enhance strength or endurance.
Effectiveness of Aprezo 30 mg Glenmark Pharmaceuticals Ltd. in sports
For athletes, Aprezo 30 mg can play a valuable role in promoting recovery after intense training. The medication’s primary effect is its ability to reduce inflammation, which can be a barrier to effective training. When athletes train hard, they may experience muscle fatigue and soreness. Aprezo aids in minimizing this discomfort, allowing athletes to train more effectively. Although it doesn’t directly impact performance like other supplements might, its anti-inflammatory properties can help maintain consistency in training regimes. This steadiness can translate to improved results over time.
Recommended dosages and cycles
In a medical context, the standard dosage for Aprezo is typically 30 mg taken twice daily after an initial titration. Athletes considering Aprezo should consult a healthcare professional to determine the best approach tailored to their unique needs, especially since specific dosage recommendations for sports are not well established. It’s crucial to follow guidance to minimize potential side effects while maximizing recovery benefits. Adjustments may be needed based on individual responses to the medication.
Positive aspects of Aprezo 30 mg Glenmark Pharmaceuticals Ltd.
There are several benefits to using Aprezo, particularly for athletes. First and foremost, its anti-inflammatory effects can significantly aid in recovery after intense workouts. This means athletes may experience less muscle soreness and stiffness, promoting more frequent and effective training sessions. Another positive aspect is that Aprezo has minimal to no impact on blood pressure and does not cause significant water retention, making it a safer choice for many. While there are potential side effects like diarrhea and headache, most individuals tolerate Aprezo well, contributing to its appeal in benign recovery strategies.
Where to buy Aprezo 30 mg Glenmark Pharmaceuticals Ltd. in America?
For those looking to purchase Aprezo 30 mg Glenmark Pharmaceuticals Ltd., our American online store offers a convenient solution. We provide a streamlined shopping experience with competitive pricing, ensuring you receive the best value. Our commitment to customer service means you can ask questions and get help whenever needed. By buying from our online store, you’ll benefit from quick shipping and excellent product quality. If you’re searching for Aprezo 30 mg Glenmark Pharmaceuticals Ltd. buy or Aprezo 30 mg Glenmark Pharmaceuticals Ltd. online, look no further; we have everything you need readily available.
| Active substance |
Apremilast |
|---|---|
| Water Retention |
No significant effect |
| Hepatotoxicity |
Minimal to no hepatotoxicity reported |
| Lab Test |
Monitoring is not typically required for liver enzymes unless under specific medical advice |
| Strength |
30mg |
| Also known as |
CC-10004 |
| Blood pressure |
No significant effects on blood pressure |
| Trade name |
Otezla |
| Storage conditions |
Store at 20В°C to 25В°C (68В°F to 77В°F), excursions permitted between 15В°C to 30В°C (59В°F to 86В°F) |
| Chemical name |
N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide |
| Formula |
C22H24N2O7S |
| Substance class |
Phosphodiesterase 4 (PDE4) inhibitor |
| Main action |
Anti-inflammatory |
| Half-life |
Approximately 6-9 hours |
| Dosage (medical) |
30 mg twice daily after initial titration |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces inflammation by inhibiting PDE4, an enzyme involved in the process of inflammatory response |
| Side effects |
Diarrhea, nausea, headache, upper respiratory tract infection, weight loss |
| Use in sports |
Not typically used in sports, lacks performance-enhancing properties |
| Manufacturer |
Glenmark Pharmaceuticals Ltd. |
| Packing |
10 tabs/blister |

Reviews
There are no reviews yet.